Studies of GJD2 rs524952 gene variants showed that the AT genotype reduced the risk of hyperopia with astigmatism by 0.53 times (95% CI: 0.888–3.907; p < 0.05) compared to TT and AA genotypes (Table 3). This evidence concerns the gene GJD2 and hyperopia.